Daiwa Pharmaceutical

Daiwa Pharmaceutical
Name	Daiwa Pharmaceutical

Daiwa Pharmaceutical is a Japan-based pharmaceutical manufacturer and distributor known for consumer health products, prescription medicines, and active pharmaceutical ingredients. The company operates in domestic and international markets, engaging in drug discovery, clinical development, and over-the-counter product marketing. Daiwa Pharmaceutical maintains collaborations and supply relationships across Asia, Europe, and North America.

History

Daiwa Pharmaceutical traces its origins to postwar industrial expansion in Japan, emerging amid the same era as companies such as Takeda Pharmaceutical Company, Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and Astellas Pharma Inc.. Early growth paralleled developments involving Japan Tobacco, Mitsubishi Chemical Holdings Corporation, and Sumitomo Chemical Company, Limited as pharmaceutical chemistry advanced. Expansion in the late 20th century coincided with regulatory shifts influenced by Ministry of Health, Labour and Welfare (Japan), international guidance from the World Health Organization, and trade frameworks involving Asia-Pacific Economic Cooperation partners. Strategic partnerships were formed with multinational firms akin to GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson for licensing and distribution. Corporate restructuring mirrored trends seen at Canon Inc. and Sony Group Corporation diversification, while research investments reflected influences from institutions like University of Tokyo, Kyoto University, and Osaka University.

Products and Research

The company’s portfolio includes over-the-counter remedies, prescription pharmaceuticals, topical formulations, and bulk active pharmaceutical ingredients. Research programs have targeted therapeutic areas comparable to efforts by Roche, Merck & Co., Bristol Myers Squibb, AstraZeneca, and Eli Lilly and Company, with pipelines addressing metabolic disorders, infectious diseases, and dermatological conditions. Preclinical and clinical work has referenced methodologies similar to those used at National Institutes of Health, Centers for Disease Control and Prevention, European Medicines Agency, and trials registered with registries like ClinicalTrials.gov. Product lines compete in markets alongside brands from Kose Corporation, Shiseido Company, Limited, Procter & Gamble, and Unilever. Collaborative research initiatives have involved biotech firms analogous to Amgen, Biogen, Gilead Sciences, and academic spin-offs from Tohoku University.

Corporate Structure and Governance

Daiwa Pharmaceutical’s governance follows a board structure with executive officers and advisory committees similar to governance practices at Mitsui & Co., Ltd., Mitsubishi Corporation, and Itochu Corporation. Stakeholder relationships include institutional investors comparable to Nomura Holdings, Inc., Mizuho Financial Group, Inc., and Sumitomo Mitsui Financial Group, Inc.. Corporate social responsibility and sustainability reporting reflect frameworks by International Finance Corporation, United Nations Global Compact, and standards such as those promoted by Securities and Exchange Commission filings in cross-listed contexts. Executive leadership has interacted with regulatory bodies including Japan Fair Trade Commission and standards organizations like International Organization for Standardization. Board-level committees echo practices at Toyota Motor Corporation and Honda Motor Co., Ltd. in risk oversight and compliance.

Manufacturing and Facilities

Manufacturing sites adhere to Good Manufacturing Practice protocols comparable to facilities operated by Takeda Pharmaceutical Company, Novo Nordisk A/S, and Bayer AG. Production capabilities span formulation, sterile filling, and chemical synthesis, with technologies influenced by process engineering groups at Mitsubishi Heavy Industries, Hitachi, Ltd., and Kawasaki Heavy Industries. Supply chain logistics incorporate partners and carriers such as Nippon Express, DHL, and Kuehne + Nagel. Quality assurance interacts with inspection regimes akin to those performed by Pharmaceuticals and Medical Devices Agency (Japan), Food and Drug Administration audits, and Medicines and Healthcare products Regulatory Agency reviews. Facilities are situated near industrial clusters like those found in Osaka Prefecture, Kanagawa Prefecture, and Aichi Prefecture.

Market Presence and Financial Performance

Daiwa Pharmaceutical competes domestically with entities including Kobayashi Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Taisho Pharmaceutical Holdings Co., Ltd., and in export markets against firms such as GlaxoSmithKline, Pfizer, and Novartis. Distribution networks leverage pharmacy chains similar to Matsumoto Kiyoshi Co., Ltd., Ainz & Tulpe Co., Ltd., and hospital purchasing groups comparable to those servicing St. Luke's International Hospital and Tokyo Medical and Dental University Hospital. Financial reporting aligns with practices observed in annual reports of Tokyo Stock Exchange–listed corporations, with revenue streams from product sales, licensing, and contract manufacturing. Market analyses reference industry data providers like IMS Health and IQVIA for competitive benchmarking.

Regulatory and Legal Matters

Regulatory compliance involves interaction with agencies such as the Pharmaceuticals and Medical Devices Agency (Japan), European Medicines Agency, U.S. Food and Drug Administration, and national regulators in export markets. Legal matters have encompassed patent prosecution before offices like the Japan Patent Office, United States Patent and Trademark Office, and litigation environments similar to cases handled by firms appearing before the Tokyo District Court and United States District Court for the District of Delaware. Safety surveillance aligns with pharmacovigilance frameworks promoted by the World Health Organization and regional pharmacovigilance networks. Export controls and trade compliance reflect international arrangements under bodies like the World Trade Organization.

Category:Pharmaceutical companies of Japan